Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open, Single-dose, Two-cycle, Two-sequence, Cross-over Design Phase I Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profile of a Single Oral DA-302168S Tablet in Healthy Subjects

NCT06534346 is registered in ClinicalTrials.gov with Chendu DIAO Pharmaceutical Group CO., LTD. as lead sponsor.

NCT NCT06534346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06534346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open, Single-dose, Two-cycle, Two-sequence, Cross-over Design Phase I Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profile of a Single Oral DA-302168S Tablet in Healthy Subjects
Lead sponsor
Chendu DIAO Pharmaceutical Group CO., LTD.
Phase
Phase 1
Overall status
Completed
Start date
July 18, 2024
Completion date
August 3, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overweight and obesity